World's Best Scientists 2026 revealed!
Jeffrey A. Meyerhardt

Jeffrey A. Meyerhardt

D-Index & Metrics

Medicine

D-Index
125
Citations
60866
World Ranking
3086
National Ranking
1703

Jeffrey A. Meyerhardt publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeffrey A. Meyerhardt sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 921 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jeffrey A. Meyerhardt D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey A. Meyerhardt sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jeffrey A. Meyerhardt is affiliated with Harvard University in the United States and has contributed extensively to the field of medicine, with a particular focus on oncology. Their research output spans over 668 publications in medicine, including 264 specifically in oncology.

Their work covers various subfields including:

  • Oncology
  • Physiology
  • Pathology and Forensic Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Key topics in their research involve:

  • Colorectal Cancer Treatments and Studies
  • Nutrition and Health in Aging
  • Colorectal Cancer Screening and Detection
  • Genetic factors in colorectal cancer
  • Nutritional Studies and Diet
  • Colorectal Cancer Surgical Treatments
  • Gastric Cancer Management and Outcomes

Meyerhardt's research has been published frequently in the following venues:

  • Journal of Clinical Oncology
  • Cancer Research
  • UNC Libraries
  • JNCI Journal of the National Cancer Institute
  • Gastroenterology

Recent significant papers authored or co-authored by Meyerhardt include:

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • American Cancer Society nutrition and physical activity guideline for cancer survivors, 2022, CA A Cancer Journal for Clinicians
  • Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline, 2022, Journal of Clinical Oncology
  • NCCN Guidelines Insights: Rectal Cancer, Version 6.2020, 2020, Journal of the National Comprehensive Cancer Network

The researcher collaborates frequently with the following co-authors:

  • Shuji Ogino
  • Andrew T. Chan
  • Charles S. Fuchs
  • Edward L. Giovannucci
  • Eileen M. O'Reilly

Best Publications

  • Nutrition and physical activity guidelines for cancer survivors.

    Cheryl L. Rock;Colleen Doyle;Wendy Demark-Wahnefried;Jeffrey A. Meyerhardt

  • Systemic Therapy for Colorectal Cancer

    Jeffrey A. Meyerhardt;Robert J. Mayer

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

    Al B. Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Mustafa A. Arain

  • Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

    Kosuke Mima;Reiko Nishihara;Zhi Rong Qian;Yin Cao

  • Physical Activity and Survival After Colorectal Cancer Diagnosis

    Jeffrey A. Meyerhardt;Edward L. Giovannucci;Michelle D. Holmes;Andrew T. Chan

  • Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

    Xiaoyun Liao;Paul Lochhead;Reiko Nishihara;Teppei Morikawa

  • Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

    Marios Giannakis;Marios Giannakis;Marios Giannakis;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Sachet A. Shukla;Sachet A. Shukla;Zhi Rong Qian

  • NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

    Shuji Ogino;Katsuhiko Nosho;Gregory J Kirkner;Takako Kawasaki

  • Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

    Jeffrey A. Meyerhardt;Denise Heseltine;Donna Niedzwiecki;Donna Hollis

  • Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    Axel Grothey;Alberto F. Sobrero;Anthony F. Shields;Takayuki Yoshino

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • Rectal cancer, version 2.2018 clinical practice guidelines in Oncology

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer

    Andrew T. Chan;Edward L. Giovannucci;Jeffrey A. Meyerhardt;Eva S. Schernhammer

  • Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer

    Jeffrey A. Meyerhardt;Donna Niedzwiecki;Donna Hollis;Leonard B. Saltz

  • Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review†

    Katsuhiko Nosho;Yoshifumi Baba;Noriko Tanaka;Kaori Shima

  • Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

    Andrew X. Zhu;Dushyant V. Sahani;Dan G. Duda;Emmanuelle di Tomaso

  • Impact of diabetes mellitus on outcomes in patients with colon cancer.

    Jeffrey A. Meyerhardt;Paul J. Catalano;Daniel G. Haller;Robert J. Mayer

  • Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

    Matthew B. Yurgelun;Matthew H. Kulke;Charles S. Fuchs;Brian A. Allen

  • Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication

    Paul Lochhead;Aya Kuchiba;Yu Imamura;Xiaoyun Liao

Frequent Co-Authors

Shuji Ogino
Shuji Ogino Brigham and Women's Hospital
Andrew T. Chan
Andrew T. Chan Harvard University
Kana Wu
Kana Wu Harvard University
Mingyang Song
Mingyang Song Harvard University
Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
Donna Niedzwiecki
Donna Niedzwiecki Duke University
Reiko Nishihara
Reiko Nishihara Harvard University
Alan P. Venook
Alan P. Venook University of California, San Francisco
Brian M. Wolpin
Brian M. Wolpin Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is just one pathway in the diverse field of healthcare. For students seeking flexibility or alternative roles, a variety of online degrees open doors to impactful careers. For those interested in leadership or hospital management, a bachelors in health administration is a valuable entry point. Graduates can work in hospitals, clinics, and public health organizations.

Advancing further, professionals may want to consider cheapest mha programs online healthcare to gain deeper management expertise and qualify for executive positions. These programs can often be completed part-time and are designed for working professionals.

For nurses aiming for the highest clinical roles, a cheapest dnp prepares graduates for advanced practice and leadership within healthcare systems. Similarly, pharmacists can advance with online pharmacy schools, which offer flexible doctoral programs for those balancing work and study.

These online options increase accessibility, making healthcare careers possible for more students and professionals across the U.S.

Best Scientists Citing Jeffrey A. Meyerhardt

Trending Scientists

Recently Published Articles